Delivery Order SPE2DB22D2214-SPE2DB24FS5WT

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,794.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of CROFAB VIALS, a critical medical commodity, to support military healthcare...
This is a delivery order under contract SPE2DB22D3011 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order is for 4,565,502,397 units of CROFAB VIALS, a pharmaceutical product, at a firm fixed price of $16,134.60. The contract has no set-aside designation and is for delivery of the items by August 20, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,655.00, is for the delivery of 4,567,923,787 units of CROFAB VIALS. The award has an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CROFAB vials, a medical product, and has a firm fixed price ceiling value of $3,941.56. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of CROFAB VIALS, a medical product, with a firm fixed price of $5,121.76 and a period of performance ending on May 19, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of CROFAB vials, a pharmaceutical product, with a ceiling value of $30,162.66 and a period of performance through March 27, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division, is the...
This federal contract award, valued at $33,186.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 1, 2025. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, valued at $43,641.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of $999,999,999 and runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies. The $1,471.35 firm fixed-price contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award, valued at $35,399.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5WT
    Delivery Order

This federal contract award, valued at $45,658.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order (SPE2DB22D2214|SPE2DB24FS5WT) with a firm fixed price pricing type and a period of performance through July 22, 2024. The contract covers the procurement of CROFAB VIALS, a pharmaceutical product, and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:42 AM